Advertisement
BIIB vs MA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIIB is a Hold and MA is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BIIB’s FA Score shows that 0 FA rating(s) are green whileMA’s FA Score has 2 green FA rating(s).
- BIIB’s FA Score: 0 green, 5 red.
- MA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BIIB’s TA Score shows that 6 TA indicator(s) are bullish while MA’s TA Score has 5 bullish TA indicator(s).
- BIIB’s TA Score: 6 bullish, 3 bearish.
- MA’s TA Score: 5 bullish, 4 bearish.
Price Growth
BIIB (@Pharmaceuticals: Major) experienced а -4.90% price change this week, while MA (@Finance/Rental/Leasing) price change was -8.80% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -1.71%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +8.52%.
The average weekly price growth across all stocks in the @Finance/Rental/Leasing industry was -0.93%. For the same industry, the average monthly price growth was +4.21%, and the average quarterly price growth was +16.27%.
Reported Earning Dates
BIIB is expected to report earnings on Jul 23, 2025.
MA is expected to report earnings on Jul 24, 2025.
Industries' Descriptions
@Pharmaceuticals: Major (-1.71% weekly)The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Finance/Rental/Leasing (-0.93% weekly)A leasing company (e.g. United Rentals, Inc. ) is typically the legal owner of the asset for the duration of the lease, while the lessee has operating control over the asset while also having some share of the economic risks and returns from the change in the valuation of the underlying asset. Per capita disposable income and corporate earnings or cash flow could be some of the critical metrics for this business – the higher the values of these metrics, the potentially greater ability of consumers/businesses to afford apartments/office spaces for rent. Other finance companies include credit/debit card payment processing companies (e.g. Visa Inc. and Mastercard), private label credit cards providers (e.g. Synchrony Financial) and automobile finance companies (e.g. Credit Acceptance Corporation).
| BIIB | MA | BIIB / MA | |
| Capitalization | 31.3B | 446B | 7% |
| EBITDA | 2.04B | 15B | 14% |
| Gain YTD | -17.251 | 2.623 | -658% |
| P/E Ratio | 26.95 | 40.44 | 67% |
| Revenue | 9.84B | 25.1B | 39% |
| Total Cash | 1.05B | 9.18B | 11% |
| Total Debt | 7.34B | 15.7B | 47% |
BIIB | MA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 11 | 22 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 87 Overvalued | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 14 | |
SMR RATING 1..100 | 71 | 11 | |
PRICE GROWTH RATING 1..100 | 64 | 56 | |
P/E GROWTH RATING 1..100 | 96 | 43 | |
SEASONALITY SCORE 1..100 | n/a | 30 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BIIB's Valuation (87) in the Biotechnology industry is in the same range as MA (95) in the Finance Or Rental Or Leasing industry. This means that BIIB’s stock grew similarly to MA’s over the last 12 months.
MA's Profit vs Risk Rating (14) in the Finance Or Rental Or Leasing industry is significantly better than the same rating for BIIB (100) in the Biotechnology industry. This means that MA’s stock grew significantly faster than BIIB’s over the last 12 months.
MA's SMR Rating (11) in the Finance Or Rental Or Leasing industry is somewhat better than the same rating for BIIB (71) in the Biotechnology industry. This means that MA’s stock grew somewhat faster than BIIB’s over the last 12 months.
MA's Price Growth Rating (56) in the Finance Or Rental Or Leasing industry is in the same range as BIIB (64) in the Biotechnology industry. This means that MA’s stock grew similarly to BIIB’s over the last 12 months.
MA's P/E Growth Rating (43) in the Finance Or Rental Or Leasing industry is somewhat better than the same rating for BIIB (96) in the Biotechnology industry. This means that MA’s stock grew somewhat faster than BIIB’s over the last 12 months.
| BIIB | MA | |
|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 67% |
| Stochastic ODDS (%) | 2 days ago 54% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 65% | 2 days ago 46% |
| MACD ODDS (%) | 2 days ago 67% | 2 days ago 54% |
| TrendWeek ODDS (%) | 2 days ago 70% | 2 days ago 49% |
| TrendMonth ODDS (%) | 2 days ago 56% | 2 days ago 47% |
| Advances ODDS (%) | 10 days ago 54% | 3 days ago 54% |
| Declines ODDS (%) | 2 days ago 70% | 7 days ago 53% |
| BollingerBands ODDS (%) | 2 days ago 63% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 55% | 2 days ago 51% |
Advertisement
BIIB and
Correlation & Price change
A.I.dvisor indicates that over the last year, BIIB has been loosely correlated with AMGN. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if BIIB jumps, then AMGN could also see price increases.
| Ticker / NAME | Correlation To BIIB | 1D Price Change % | ||
|---|---|---|---|---|
| BIIB | 100% | -0.02% | ||
| AMGN - BIIB | 53% Loosely correlated | -0.14% | ||
| PFE - BIIB | 49% Loosely correlated | -0.50% | ||
| NVS - BIIB | 46% Loosely correlated | -0.39% | ||
| SNY - BIIB | 43% Loosely correlated | -1.24% | ||
| GSK - BIIB | 43% Loosely correlated | -2.72% | ||
More | ||||